Group items tagged

This Funding Opportunity Announcement (FOA), issued by the National Institute of Nursing Research (NINR), is intended to encourage Research Project Grant (R01) applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. Applications to promote positive health behavior(s) should target social and cultural contexts, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors.

USAID is seeking to enhance our malaria vaccine investments through a collaborative design process. The goal of USAID's Malaria Vaccine Development Program (MVDP) is to demonstrate the proof of concept of a vaccine to reduce morbidity and mortality due to malaria caused by infection with Plasmodium falciparum. Target malaria vaccine end characteristics will include at least 75% efficacy and evidence of affordability. USAID intends to support efforts towards vaccines that have the potential to directly protect recipients against disease caused by P. falciparum such as vaccines that target the pre-erythrocytic (sporozoite and liver stage) and erythrocytic stages of the life cycle. The purpose of this Addendum is to solicit Expressions of Interest (EOI) for novel and innovative approaches to malaria vaccine development that would encompass preclinical development through proof of principle clinical studies to motivate advanced development of a deployable, effective malaria vaccine.

The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. Research supported by this FOA must include rigorous validation studies to demonstrate the robustness of the target as a pain treatment target. This will lower the risk of adopting the target in translational projects to develop small molecules, biologics, natural substances, or devices that interact with this target for new pain treatments. Translational research to develop new medical devices are not the focus of this FOA. Basic science studies of pain and related systems in the body are responsive to this FOA and are encouraged in the context of novel pain therapeutic target discovery. This FOA is not specific for any one or group of pain conditions. Projects to identify novel targets for acute pain, chronic pain, migraine, other headache disorders, osteoarthritis, diabetic neuropathy, chemotherapy-induced neuropathy, sickle-cell pain, post stroke pain, etc. will be considered. Projects to identify novel targets for a combination of chronic overlapping pain conditions or for specific pathological conditions will be considered. Projects that seek to identify novel targets in specific populations such as women, children, older adults or other underrepresented groups will also be responsive to this FOA.

The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs offer separate K01 FOAs intended to increase research workforce diversity.

The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and "protected time" (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs offer separate K01 FOAs intended to increase research workforce diversity.

TRANSLATIONAL MEDICINE AND THERAPEUTICS: The goal of the PhRMA Foundation's Translational Medicine and Therapeutics Program is to promote the development and use of experimental and computational methods in an integrative approach towards clinical needs in diagnosis, treatment and prevention. This can involve enhanced understanding of human biological and disease processes but requires a strong translational component. This program will support the concepts of Translational Medicine and Therapeutics as defined by the Foundation: "Translational medicine and therapeutics is a discipline focused on bridging experimental and computational technologies and discoveries in the research laboratory to their application in clinical practice. Examples of research components include activities in molecular and cellular biology, pathophysiology, systems biology, bioinformatics, modeling and simulation, and other quantitative sciences to connect basic biological concepts and entities to directly address unmet medical needs. The goals are to use clinical observation as the basis for hypothesis generation to further basic research and to efficiently advance the product of basic research to patients." Translational Medicine and Therapeutics awards will advance training and support career development of scientists engaged in research that significantly integrates cutting-edge technologies with advanced biological, chemical, and pharmacological sciences and engineering methodologies in such areas as (but not restricted to): * Genetics (Molecular, Pharmaco-, Population, Medical) * Genomics (Functional, Structural, Toxico-, Pharmaco-, Comparative) * Systems (Biology and Pharmacology) * Pathways and networks * Integrative biology * Modeling and simulation * Target Identification and Validation * Biomarker Discovery and Validation * Vaccine Development * Molecular Epidimiology * Imaging * Disease Modeling

This Funding Opportunity Announcement invites applications to establish Centers of Excellence for Self-Management Research: Building Research Teams for the Future (P20). The purpose of the program is to enhance interdisciplinary, biobehavioral research for scientists conducting self-management research by enabling development of a sustainable research infrastructure and centralized resources in support of research programs in various science areas. The purpose of the P20 Center is to: (1) develop new and a potential sustainable interdisciplinary, biobehavioral research capacity for scientists conducting nursing research by establishing centralized research resources and a research infrastructure; (2) build the Centers thematic science area through complementary, synergistic research activities; and (3) begin to grow feasibility research that will develop into new research teams of the future and independent investigator research applications.

PART A -- Core Curricular Enhancements Strategic Direction A2 -- Promote educational enhancements that include transdisciplinary and interprofessional population health training Activity I: Medical Assistants Resources and Training on Immunization (MARTi) MARTi is a website http://www.marti-us.org/ hosted and updated by the Association for Prevention Teaching and Research (APTR). MARTi was developed to provide a collection of immunization training, education, and resource materials for medical assistants and those responsible for their training, such as office managers or supervisors. The website provides reviewed and credible training and education programs and resources specifically developed for the education and reading level of medical assistants. Activities will include the following: --Manage and update the website content and resources as new vaccine recommendations and best practices become available and redesign the navigation of the website to feature resources offering continuing education (CE) credits --Create newsletters and social media announcements --Develop responsive design website to provide access through mobile devices --Assemble a committee of experts to advance use of the website and recommend improvements. Committee will convene via conference call (3 or 4 times a year). The committee will consist of key groups including the American Association of Medical Assistants (AAMA) and the Professional Association of Healthcare Organization Management (PACHOM) as well as post-secondary institutions training future medical assistants. CDC will not direct or manage any aspects of the committee.

The purpose of this Notice of Funding Opportunity (NOFO) is support applied research that will develop, advance, and apply mathematical models to investigate the utility and impact of prevention and control strategies for seasonal and pandemic influenza, including vaccination and treatment. This NOFO will establish a network of Influenza Modeling Centers that conducts research to facilitate the rapid development, harmonization, validation, synthesis, and communication of multiple mathematical models and their results for seasonal and pandemic influenza prevention and control. This NOFO is expected to generate advancements in the rapid sharing of validated modeling results from multiple models that will improve the evidence base for public health action and policy development.

The objectives of the Lifespan Respite Technical Assistance and Resource Center (TARC) is to provide technical assistance to the Lifespan Respite Program grantees and the field. The primary objectives of this funding opportunity are: (1) further identify, develop, and disseminate training and TA resources to ACL's Lifespan Respite Program grantees (past, present and future) that address the role of respite as a means to supporting families in their own development of natural supports; (2) strengthen the national capacities at the federal, state and local levels to provide respite services as an essential family support across the age and disability spectrum; and (3) support activities and innovations to develop an evidence base for respite care and related services.

The purpose of this Funding Opportunity Announcement [FOA] submitted through the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to stimulate the development and validation of novel tools and analytical methods to target, identify and characterize non-neuronal cells in the brain. This FOA complements previous and ongoing cell-census and tool development efforts initiated under BRAIN, RFA-MH-14-215 and RFA-MH-14-216, that have focused almost exclusively on neuronal cells. The cutting-edge tools and methods developed under this opportunity should focus specifically on providing improved points of entry into non-neuronal cell-types (glial and vascular) to enable their inventory and characterization within the CNS and help define how these cells interact among each other and with neuronal cells to impact functional circuitries. Plans for validating the utility of the tool/technology/method and demonstrating its advantage over currently available approaches will be an essential feature of a successful application. Tools that can be used in several species or model organisms rather than in a single species are especially desirable.

The awarded VBSN applications will:                        ·          Reduce barriers that prevent veterans from transitioning into nursing careers;                        ·          Develop BSN career ladder programs targeted to the unique needs of veterans;                        ·          Explore innovative educational models to award academic credit for prior health care experience/training or other relevant military training;                        ·          Address the growing national demand for BSN prepared Registered Nurses; and                        ·          Improve employment opportunities for veterans through high demand careers training as outlined in the Veterans Opportunity to Work under the VOW to Hire Heroes Act of 2011, www.benefits.va.gov/VOW. For FY13, the Division of Nursing (DN) seeks four-year cooperative agreement applications that propose to develop and implement career ladder programs to increase the enrollment of veterans in BSN programs. 

The Global Health Research Innovation Center (GHRIC) is pleased to announce a call for proposals for faculty research grants. These grants are designed to foster the development of research initiatives and partnership projects in global health. Grants will be made to Miami faculty to undertake small-scale, collaborative pilot research projects in global health and/or travel (of Miami faculty or domestic/international collaborators) to cultivate research relationships through establishing institutional linkages and jointly developing or writing research proposals. The expectation is that at least one outcome of each project will be the submission of an external grant proposal. Proposed projects must involve at least two Miami faculty members from different departments. Budgets are expected to be between $4000-$8000. We expect to award at least 2 grants for the 2016-2017 academic year. If funded, additional funding of up to $1000 may be available to help support presentation of the proposed project at either the annual conference of the Consortium of Universities for Global Health or the Global Health and Innovation Conference (Unite for Sight).

The National Institutes of Health (NIH) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in categorical program areas. The R21 activity code is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

The goal of the Robert Wood Johnson Foundation Nurse Faculty Scholars program is to develop the next generation of national leaders in academic nursing through career development awards for outstanding junior nursing faculty. The program aims to strengthen the academic productivity and overall excellence of nursing schools by providing mentorship, leadership training, and salary and research support to young faculty.

The Academic Education Scholarship was implemented as a means of helping PENS to meet its goal of advancing the art and science of pediatric endocrine nursing. PENS is committed to increasing the knowledge base and enhancing the professional development of nurses in the field of pediatric endocrinology. Education is one of several means of professional development, and PENS has provided the Academic Education Scholarship to help its members meet academic goals.

he NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The goal of this NHLBI R25 program is to enhance the diversity of the biomedical, behavioral and clinical research workforce . To this end, this funding opportunity announcement encourages the development of creative educational activities with a primary focus on Research Experiences, Courses for Skills Development and Mentoring Activities.

The Air Force Office of Scientific Research (AFOSR) seeks unclassified proposals for broad-based research and development aimed at using lasers and other light source technology to develop applications in medicine, photobiology, surgery, and closely related materials sciences, with applications to combat casualty care and other military medical problems. This announcement is primarily directed toward university-based medical institutions; however, all qualified and responsible prime applicants located in the United States are eligible to submit proposals. The highest priority will be extended to proposals up to three (3) years duration to be conducted by teams of physicians, biomedical scientists, physical scientists, and engineers. The efforts proposed may be basic or applied research, and must have direct relevance to combat casualty care or other military medical priorities. Applicants must demonstrate substantial experience working to further military medical priorities, including transitioning research into clinical practice and working products. Substantial experience collaborating with military medical centers is also a requirement to establish relevance to combat casualty care or other military medical priorities, and facilitate the transition of research results to meet military needs. Applicants are encouraged to apply as early as practicable. Proposals may be reviewed and selected as received. Awards may take the form of grants or contracts

The purpose of this contract is to establish a NIAID resource entitled "EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES" that provides a suite of preclinical, nonclinical, and clinical testing services for vaccines and other biologic products. While the overall suite of testing services is comprehensive, the intent is to provide individual services on a case-by-case basis for a diverse collection of vaccine and biological product candidates, rather than carry a single product candidate through an entire preclinical development pathway. These services are intended to help a wide variety of investigators in a broad number of scientific areas obtain critical data needed to acquire additional funding, gain prospective partnerships (either for further development or to support Phase I/II/III trials), fulfill regulatory requirements, and complete studies needed to apply for an IND and enter Phase I/II/III trials.

This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to establish Centers of collaborating investigators with the goal of identifying and advancing research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Recommendation (B) that calls for the establishment of a pediatric immunotherapy translational science network. The network was envisioned by the BRP as focusing on identifying new targets for immunotherapies, developing new pediatric immunotherapy treatment approaches (e.g., cancer vaccines, cellular therapy, combinations of immunotherapy agents, and others), and defining the biological mechanisms by which pediatric tumors evade the immune system. The Pediatric Immunotherapy Discovery and Development Network (PI-DDN) Centers will address and implement these BRP recommendations.